NCT05787223 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Ackland P, Resnikoff S, Bourne R
World blindness and visual impairment: despite many successes, the problem is growing. Community Eye Health. 2017;30(100):71-73. No abstract available.
Behar MP, Zucker DRJJoVI, Blindness
Sensory Awareness Exercises for the Visually Handicapped. 1976;70(4):146-8.
Lewis V, Norgate S, Collis G, Reynolds RJBJoDP
The consequences of visual impairment for children's symbolic and functional play. 2000;18(3):449-64.
Parreira RB, Grecco LAC, Oliveira CS
Postural control in blind individuals: A systematic review. Gait Posture. 2017 Sep;57:161-167. doi: 10.1016/j.gaitpost.2017.06.008. Epub 2017 Jun 12.
Winnick JP
The Performance of Visually Impaired Youngsters in Physical Education Activities: Implications for Mainstreaming. 1985;2(4).

Effects of Balance Training Exercises on Mobility in Open and Closed Environment in Children With Visual Impairments.

Clinical trial NCT05787223 - References